Dyne Therapeutics (NASDAQ:DYN) Price Target Cut to $46.00 by Analysts at HC Wainwright
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its target price reduced by HC Wainwright from $55.00 to $46.00 in a research report report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ Q1 2025 earnings at ($0.90) EPS, Q2 2025 earnings at […]
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its target price reduced by HC Wainwright from $55.00 to $46.00 in a research report report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ Q1 2025 earnings at ($0.90) EPS, Q2 2025 earnings at […]
